NBY

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NovaBay Pharmaceuticals Inc

NYSE MKT | NBY

1.04

USD

$0.00

(

0.00%

)

At Close (As of Oct 17, 2025)

$6.85M

Market Cap

0.452

P/E Ratio

2.3

EPS

$2.93

52 Week High

$0.30

52 Week Low

HEALTHCARE

Sector

NBY Chart

Recent Chart
Price Action

NBY Technicals

Tags:

NBY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.5M
Total Revenue $9.8M
Cost Of Revenue $3.3M
Costof Goods And Services Sold $3.3M
Operating Income -$5.8M
Selling General And Administrative $7.4M
Research And Development $42K
Operating Expenses $12M
Investment Income Net -
Net Interest Income -$904K
Interest Income $96K
Interest Expense $904K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $381K
Income Before Tax -$7.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.2M
Comprehensive Income Net Of Tax -
Ebit -$6.3M
Ebitda -$5.9M
Net Income -$7.2M

Revenue & Profitability

Earnings Performance

NBY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $3.4M
Total Current Assets $1.9M
Cash And Cash Equivalents At Carrying Value $430K
Cash And Short Term Investments $430K
Inventory $765K
Current Net Receivables $389K
Total Non Current Assets $1.5M
Property Plant Equipment $1M
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $351K
Other Non Current Assets -
Total Liabilities $3.6M
Total Current Liabilities $2.8M
Current Accounts Payable $623K
Deferred Revenue -
Current Debt -
Short Term Debt $963K
Total Non Current Liabilities $709K
Capital Lease Obligations $1.1M
Long Term Debt -
Current Long Term Debt $565K
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7M
Other Current Liabilities $769K
Other Non Current Liabilities -
Total Shareholder Equity -$129K
Treasury Stock -
Retained Earnings -$183M
Common Stock $49K
Common Stock Shares Outstanding $3.4M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$5.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $381K
Capital Expenditures $6K
Change In Receivables -
Change In Inventory -$272K
Profit Loss -
Cashflow From Investment $1.1M
Cashflow From Financing $1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $3.1M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$7.1M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.5M
Total Revenue $9.8M
Cost Of Revenue $3.3M
Costof Goods And Services Sold $3.3M
Operating Income -$5.8M
Selling General And Administrative $7.4M
Research And Development $42K
Operating Expenses $12M
Investment Income Net -
Net Interest Income -$904K
Interest Income $96K
Interest Expense $904K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $381K
Income Before Tax -$7.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.2M
Comprehensive Income Net Of Tax -
Ebit -$6.3M
Ebitda -$5.9M
Net Income -$7.2M

Dividends

Field Value
Ex Dividend Date 2025-09-30
Declaration Date 2025-08-26
Record Date 2025-09-15
Payment Date 2025-09-29
Amount 0.8

NBY Profile

NovaBay Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

NovaBay Pharmaceuticals Inc. (NBY) is a California-based medical device innovator specializing in advanced ocular health solutions. The company leverages proprietary technologies to develop therapeutics for eye infections and inflammation, addressing significant unmet clinical needs. With a commitment to improving patient outcomes and a strategic focus on the growing eye care market, NovaBay presents an appealing opportunity for institutional investors targeting the healthcare and medical device sectors.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
WOK
-31.91%
$0.03
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
WOK
-31.91%
$0.03
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.